<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01565967</url>
  </required_header>
  <id_info>
    <org_study_id>AutoLog</org_study_id>
    <nct_id>NCT01565967</nct_id>
  </id_info>
  <brief_title>Registry AutoLog Lipid Removal and Blood Component Characterization</brief_title>
  <official_title>Registry AutoLog Lipid Removal and Blood Component Characterization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to show the success of the AutoLog System in removing lipids to
      less than 10mg/dl in vivo. The Autolog registry has two objectives:

        1. to determine the lipid removal capabilities of the Medtronic AutoLog System.

        2. to obtain in vivo data on blood component removal and washing capabilities of the
           Medtronic AutoLog System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since the in house data strongly suggest that the Medtronic AutoLog is uniquely high
      performing in lipid removal in-vitro, the Registry AutoLog Lipid Removal and Blood Component
      Characterization is initiated to determine if the AutoLog system is successful in removing
      lipids in vivo as it is in-vitro. Therefore, it is expected that the lipid amounts after
      washing will be less than 10 mg/dl.

      The study is designed as a multi-center, non-randomized, non-interventional, post market
      release study (a registry). The study has a single arm, without controls, as it is
      descriptive in nature.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>level of reduction of nonemulsified fat</measure>
    <time_frame>after process</time_frame>
    <description>The primary endpoint of this study is the level of reduction of nonemulsified fat after processing through the Medtronic AutoLog.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">199</enrollment>
  <condition>Trauma</condition>
  <arm_group>
    <arm_group_label>Autotransfusion</arm_group_label>
    <description>All patients undergoing surgery which requires routine use of an autotransfusion system</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood and washed blood will be collected from each patient
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The subject population includes all subjects with an indication for cardiac surgery,
        orthopedic surgery etc. in which the hospital treatment protocol requires the routine use
        of an autotransfusion system, and who meet the inclusion and exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with an indication for surgery procedures in which the hospital treatment
             protocol requires the routine use of an autotransfusion system are eligible for
             participation.

        Exclusion Criteria:

          -  The use of citrate-based anticoagulant in patients with impaired liver function

          -  Gross contamination and/or septic procedures

          -  Surgery within the malignant area that may allow dissemination of tumor/malignant
             cells, if aspirated, into the autotransfusion system

          -  Caesarean sections in presence of amniotic fluid

          -  Presence of high concentrations of prostatic fluid

          -  Contamination of salvaged blood with drugs not intended for intravenous administration

          -  Use of collagen-based haemostatic agents and gel foam used in combination with any
             autotransfusion system

          -  Coagulopathy

          -  Not willing to sign a Patient Informed Consent/Data Release Form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Materdomini</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius University Hospital Santariskiu Klinikos</name>
      <address>
        <city>Vilnius</city>
        <zip>08861</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut national de chirurgie cardiaque et de cardiologie interventionnelle (INCCI)</name>
      <address>
        <city>Luxembourg</city>
        <zip>1210</zip>
        <country>Luxembourg</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VU Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <zip>1007MB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zuid-Afrikaans Hospital</name>
      <address>
        <city>Pretoria</city>
        <zip>0002</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitetssjukhuset i Lund</name>
      <address>
        <city>Lund</city>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Lithuania</country>
    <country>Luxembourg</country>
    <country>Netherlands</country>
    <country>South Africa</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2011</study_first_submitted>
  <study_first_submitted_qc>March 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2012</study_first_posted>
  <last_update_submitted>October 28, 2015</last_update_submitted>
  <last_update_submitted_qc>October 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AutoLog</keyword>
  <keyword>Post market release</keyword>
  <keyword>Non-interventional</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

